ABSTRACTThe presence of meconium‐stained amniotic fluid is a matter of importance when considering intrapartum management. Meconium‐stained amniotic fluid is known to be associated with increased fetal and maternal risks, especially when fetal exposure has been extended and the fluid is concentrated. Selected primary and secondary sources are referenced in a summary that examines the implications and management of meconium‐stained amniotic fluid for the newborn. The use of amnioinfusion in selected cases with oligohydramnios or meconium‐stained fluid is di